| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.55 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |